Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Molina Healthcare (MOH) Receives a Buy from Bernstein

Tipranks - Tipranks - Wed Apr 8, 6:42AM CDT

Bernstein analyst Lance Wilkes assigned a Buy rating to Molina Healthcare yesterday and set a price target of $173.00. The company’s shares closed yesterday at $143.36.

Easter Sale - 70% Off TipRanks

Wilkes covers the Healthcare sector, focusing on stocks such as Cigna, Centene, and CVS Health. According to TipRanks, Wilkes has an average return of -8.7% and a 32.67% success rate on recommended stocks.

Currently, the analyst consensus on Molina Healthcare is a Hold with an average price target of $143.54.

See Insiders’ Hot Stocks on TipRanks >>

Based on Molina Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $11.38 billion and a GAAP net loss of $160 million. In comparison, last year the company earned a revenue of $10.5 billion and had a net profit of $251 million

Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is neutral on the stock. Last month, Ronna Romney, a Director at MOH sold 506.00 shares for a total of $74,341.52.

Read More on MOH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).